Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 7, 2017; 23(33): 6155-6163
Published online Sep 7, 2017. doi: 10.3748/wjg.v23.i33.6155
Table 1 Clinical backgrounds of the study subjects n (%)
TotalGroup A:Group B:Group C:Group A vs B,Group A vs C,
No chromosome aberration1t(11;18) positiveExtra copies of MALT1p valuep value
n146882731
Sex
Male70 (47.9)40 (45.5)17 (63.0)13 (41.9)0.110.73
Female76 (52.1)48 (54.5)10 (37.0)18 (58.1)
Age (mean ± SD, yr)65.4 ± 12.665.9 ± 12.364.2 ± 11.265.0 ± 14.90.530.75
Stage (Lugano system)
I1318124260.9220.292
II13111
II21100
IV11524
H. pylori
Positive89 (61.0)66 (75.0)2 (7.4)21 (67.7)< 0.010.439
Negative57 (39.0)22 (25.0)25 (92.6)10 (32.3)